BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: György B, Sage C, Indzhykulian AA, Scheffer DI, Brisson AR, Tan S, Wu X, Volak A, Mu D, Tamvakologos PI, Li Y, Fitzpatrick Z, Ericsson M, Breakefield XO, Corey DP, Maguire CA. Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV. Mol Ther 2017;25:379-91. [PMID: 28082074 DOI: 10.1016/j.ymthe.2016.12.010] [Cited by in Crossref: 108] [Cited by in F6Publishing: 101] [Article Influence: 21.6] [Reference Citation Analysis]
Number Citing Articles
1 Wang L, Kempton JB, Brigande JV. Gene Therapy in Mouse Models of Deafness and Balance Dysfunction. Front Mol Neurosci 2018;11:300. [PMID: 30210291 DOI: 10.3389/fnmol.2018.00300] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
2 Martin DM, Raphael Y. It's All in the Delivery: Improving AAV Transfection Efficiency with Exosomes. Mol Ther 2017;25:309-11. [PMID: 28126363 DOI: 10.1016/j.ymthe.2017.01.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
3 O'Brien K, Breyne K, Ughetto S, Laurent LC, Breakefield XO. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat Rev Mol Cell Biol 2020;21:585-606. [PMID: 32457507 DOI: 10.1038/s41580-020-0251-y] [Cited by in Crossref: 182] [Cited by in F6Publishing: 205] [Article Influence: 91.0] [Reference Citation Analysis]
4 Rankovic V, Vogl C, Dörje NM, Bahader I, Duque-Afonso CJ, Thirumalai A, Weber T, Kusch K, Strenzke N, Moser T. Overloaded Adeno-Associated Virus as a Novel Gene Therapeutic Tool for Otoferlin-Related Deafness. Front Mol Neurosci 2020;13:600051. [PMID: 33488357 DOI: 10.3389/fnmol.2020.600051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Yoshimura H, Nishio SY, Usami SI. Milestones toward cochlear gene therapy for patients with hereditary hearing loss. Laryngoscope Investig Otolaryngol 2021;6:958-67. [PMID: 34693000 DOI: 10.1002/lio2.633] [Reference Citation Analysis]
6 Elmore ZC, Patrick Havlik L, Oh DK, Anderson L, Daaboul G, Devlin GW, Vincent HA, Asokan A. The membrane associated accessory protein is an adeno-associated viral egress factor. Nat Commun 2021;12:6239. [PMID: 34716331 DOI: 10.1038/s41467-021-26485-4] [Reference Citation Analysis]
7 Breuer CB, Hanlon KS, Natasan JS, Volak A, Meliani A, Mingozzi F, Kleinstiver BP, Moon JJ, Maguire CA. In vivo engineering of lymphocytes after systemic exosome-associated AAV delivery. Sci Rep 2020;10:4544. [PMID: 32161326 DOI: 10.1038/s41598-020-61518-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
8 Kleinlogel S, Vogl C, Jeschke M, Neef J, Moser T. Emerging approaches for restoration of hearing and vision. Physiological Reviews. [DOI: 10.1152/physrev.00035.2019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
9 Holkar K, Vaidya A, Pethe P, Kale V, Ingavle G. Biomaterials and extracellular vesicles in cell-free therapy for bone repair and regeneration: Future line of treatment in regenerative medicine. Materialia 2020;12:100736. [DOI: 10.1016/j.mtla.2020.100736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Mittal R, Nguyen D, Patel AP, Debs LH, Mittal J, Yan D, Eshraghi AA, Van De Water TR, Liu XZ. Recent Advancements in the Regeneration of Auditory Hair Cells and Hearing Restoration. Front Mol Neurosci 2017;10:236. [PMID: 28824370 DOI: 10.3389/fnmol.2017.00236] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
11 Verdoodt D, Peeleman N, Van Camp G, Van Rompaey V, Ponsaerts P. Transduction Efficiency and Immunogenicity of Viral Vectors for Cochlear Gene Therapy: A Systematic Review of Preclinical Animal Studies. Front Cell Neurosci 2021;15:728610. [PMID: 34526880 DOI: 10.3389/fncel.2021.728610] [Reference Citation Analysis]
12 Muhuri M, Gao G. Membranous Bubbles: High-Purity and High-Titer Exosomes as the Potential Solution for Adeno-Associated Viruses to Evade Neutralization? Hum Gene Ther 2021;32:1427-9. [PMID: 34935455 DOI: 10.1089/hum.2021.29189.mmu] [Reference Citation Analysis]
13 Maguire CA, Corey DP. Viral vectors for gene delivery to the inner ear. Hear Res 2020;394:107927. [PMID: 32199720 DOI: 10.1016/j.heares.2020.107927] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
14 Lugin ML, Lee RT, Kwon YJ. Synthetically Engineered Adeno-Associated Virus for Efficient, Safe, and Versatile Gene Therapy Applications. ACS Nano 2020;14:14262-83. [PMID: 33073995 DOI: 10.1021/acsnano.0c03850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Geng R, Omar A, Gopal SR, Chen DH, Stepanyan R, Basch ML, Dinculescu A, Furness DN, Saperstein D, Hauswirth W, Lustig LR, Alagramam KN. Modeling and Preventing Progressive Hearing Loss in Usher Syndrome III. Sci Rep 2017;7:13480. [PMID: 29044151 DOI: 10.1038/s41598-017-13620-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
16 Oestreicher D, Picher MM, Rankovic V, Moser T, Pangrsic T. Cabp2-Gene Therapy Restores Inner Hair Cell Calcium Currents and Improves Hearing in a DFNB93 Mouse Model. Front Mol Neurosci 2021;14:689415. [PMID: 34489639 DOI: 10.3389/fnmol.2021.689415] [Reference Citation Analysis]
17 Park DJ. Standardized Methodologies to Utilize Exosome Treatment as Potential Nano Substances in Hearing Loss. OHBM 2021;2:6. [DOI: 10.3390/ohbm2020006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kovács OT, Soltész-Katona E, Marton N, Baricza E, Hunyady L, Turu G, Nagy G. Impact of Medium-Sized Extracellular Vesicles on the Transduction Efficiency of Adeno-Associated Viruses in Neuronal and Primary Astrocyte Cell Cultures. Int J Mol Sci 2021;22:4221. [PMID: 33921740 DOI: 10.3390/ijms22084221] [Reference Citation Analysis]
19 Orefice NS. Development of New Strategies Using Extracellular Vesicles Loaded with Exogenous Nucleic Acid. Pharmaceutics 2020;12:E705. [PMID: 32722622 DOI: 10.3390/pharmaceutics12080705] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
20 Kalinec GM, Gao L, Cohn W, Whitelegge JP, Faull KF, Kalinec F. Extracellular Vesicles From Auditory Cells as Nanocarriers for Anti-inflammatory Drugs and Pro-resolving Mediators. Front Cell Neurosci 2019;13:530. [PMID: 31849615 DOI: 10.3389/fncel.2019.00530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
21 Schilder AG, Su MP, Mandavia R, Anderson CR, Landry E, Ferdous T, Blackshaw H. Early phase trials of novel hearing therapeutics: Avenues and opportunities. Hearing Research 2019;380:175-86. [DOI: 10.1016/j.heares.2019.07.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
22 Mu Y, Su H, Wu F, Yang J, Li D. Research Progress of Hair Cell Protection Mechanism. Neural Plast 2020;2020:8850447. [PMID: 33133179 DOI: 10.1155/2020/8850447] [Reference Citation Analysis]
23 Ivanchenko MV, Hanlon KS, Hathaway DM, Klein AJ, Peters CW, Li Y, Tamvakologos PI, Nammour J, Maguire CA, Corey DP. AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear. Mol Ther Methods Clin Dev 2021;21:382-98. [PMID: 33869656 DOI: 10.1016/j.omtm.2021.03.019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Piffoux M, Volatron J, Cherukula K, Aubertin K, Wilhelm C, Silva AKA, Gazeau F. Engineering and loading therapeutic extracellular vesicles for clinical translation: A data reporting frame for comparability. Adv Drug Deliv Rev 2021;178:113972. [PMID: 34509573 DOI: 10.1016/j.addr.2021.113972] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Erickson T, Pacentine IV, Venuto A, Clemens R, Nicolson T. The lhfpl5 Ohnologs lhfpl5a and lhfpl5b Are Required for Mechanotransduction in Distinct Populations of Sensory Hair Cells in Zebrafish. Front Mol Neurosci 2019;12:320. [PMID: 32009898 DOI: 10.3389/fnmol.2019.00320] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
26 Hull JA, Mietzsch M, Chipman P, Strugatsky D, McKenna R. Structural characterization of an envelope-associated adeno-associated virus type 2 capsid. Virology 2022;565:22-8. [PMID: 34638006 DOI: 10.1016/j.virol.2021.09.010] [Reference Citation Analysis]
27 Goodwin MS, Croft CL, Futch HS, Ryu D, Ceballos-Diaz C, Liu X, Paterno G, Mejia C, Deng D, Menezes K, Londono L, Arjona K, Parianos M, Truong V, Rostonics E, Hernandez A, Boye SL, Boye SE, Levites Y, Cruz PE, Golde TE. Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNS. Mol Neurodegener 2020;15:15. [PMID: 32122372 DOI: 10.1186/s13024-020-00361-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Davenport EC, Pendolino V, Kontou G, McGee TP, Sheehan DF, López-Doménech G, Farrant M, Kittler JT. An Essential Role for the Tetraspanin LHFPL4 in the Cell-Type-Specific Targeting and Clustering of Synaptic GABAA Receptors. Cell Rep 2017;21:70-83. [PMID: 28978485 DOI: 10.1016/j.celrep.2017.09.025] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 12.0] [Reference Citation Analysis]
29 Calvet C, Lahlou G, Safieddine S. [Gene therapy progress: hopes for Usher syndrome]. Med Sci (Paris) 2018;34:842-8. [PMID: 30451679 DOI: 10.1051/medsci/2018210] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Cheng M, Dietz L, Gong Y, Eichler F, Nammour J, Ng C, Grimm D, Maguire CA. Neutralizing antibody evasion and transduction with purified extracellular vesicle-enveloped AAV vectors. Hum Gene Ther 2021. [PMID: 34445894 DOI: 10.1089/hum.2021.122] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Wagner HJ, Weber W, Fussenegger M. Synthetic Biology: Emerging Concepts to Design and Advance Adeno-Associated Viral Vectors for Gene Therapy. Adv Sci (Weinh) 2021;8:2004018. [PMID: 33977059 DOI: 10.1002/advs.202004018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Jurgielewicz B, Stice S, Yao Y. Therapeutic Potential of Nucleic Acids when Combined with Extracellular Vesicles. Aging Dis 2021;12:1476-93. [PMID: 34527423 DOI: 10.14336/AD.2021.0708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Guo C, Huang SS, Yuan YY, Zhou Y, Wang N, Kang DY, Yang SY, Zhang X, Gao X, Dai P. Hearing Phenotypes of Patients with Hearing Loss Homozygous for the GJB2 c.235delc Mutation. Neural Plast 2020;2020:8841522. [PMID: 32802038 DOI: 10.1155/2020/8841522] [Reference Citation Analysis]
34 Shao H, Im H, Castro CM, Breakefield X, Weissleder R, Lee H. New Technologies for Analysis of Extracellular Vesicles. Chem Rev. 2018;118:1917-1950. [PMID: 29384376 DOI: 10.1021/acs.chemrev.7b00534] [Cited by in Crossref: 394] [Cited by in F6Publishing: 393] [Article Influence: 98.5] [Reference Citation Analysis]
35 Tan F, Chu C, Qi J, Li W, You D, Li K, Chen X, Zhao W, Cheng C, Liu X, Qiao Y, Su B, He S, Zhong C, Li H, Chai R, Zhong G. AAV-ie enables safe and efficient gene transfer to inner ear cells. Nat Commun 2019;10:3733. [PMID: 31427575 DOI: 10.1038/s41467-019-11687-8] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 19.0] [Reference Citation Analysis]
36 Sancho-albero M, Medel-martínez A, Martín-duque P. Use of exosomes as vectors to carry advanced therapies. RSC Adv 2020;10:23975-87. [DOI: 10.1039/d0ra02414g] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
37 Kooijmans SAA, de Jong OG, Schiffelers RM. Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design. Adv Drug Deliv Rev 2021;173:252-78. [PMID: 33798644 DOI: 10.1016/j.addr.2021.03.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
38 Chuo ST, Chien JC, Lai CP. Imaging extracellular vesicles: current and emerging methods. J Biomed Sci 2018;25:91. [PMID: 30580764 DOI: 10.1186/s12929-018-0494-5] [Cited by in Crossref: 102] [Cited by in F6Publishing: 95] [Article Influence: 25.5] [Reference Citation Analysis]
39 Hastings ML, Brigande JV. Fetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction. Hear Res 2020;394:107931. [PMID: 32173115 DOI: 10.1016/j.heares.2020.107931] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
40 Niggemann P, György B, Chen ZY. Genome and base editing for genetic hearing loss. Hear Res 2020;394:107958. [PMID: 32334889 DOI: 10.1016/j.heares.2020.107958] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
41 Leake PA, Rebscher SJ, Dore' C, Akil O. AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF. J Assoc Res Otolaryngol 2019;20:341-61. [PMID: 31222416 DOI: 10.1007/s10162-019-00723-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
42 Wang L, Kempton JB, Jiang H, Jodelka FM, Brigande AM, Dumont RA, Rigo F, Lentz JJ, Hastings ML, Brigande JV. Fetal antisense oligonucleotide therapy for congenital deafness and vestibular dysfunction. Nucleic Acids Res 2020;48:5065-80. [PMID: 32249312 DOI: 10.1093/nar/gkaa194] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
43 Nidetz NF, McGee MC, Tse LV, Li C, Cong L, Li Y, Huang W. Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery. Pharmacol Ther 2020;207:107453. [PMID: 31836454 DOI: 10.1016/j.pharmthera.2019.107453] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 13.3] [Reference Citation Analysis]
44 Wu J, Solanes P, Nist-Lund C, Spataro S, Shubina-Oleinik O, Marcovich I, Goldberg H, Schneider BL, Holt JR. Single and Dual Vector Gene Therapy with AAV9-PHP.B Rescues Hearing in Tmc1 Mutant Mice. Mol Ther 2021;29:973-88. [PMID: 33212302 DOI: 10.1016/j.ymthe.2020.11.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
45 Pan X, Veroniaina H, Su N, Sha K, Jiang F, Wu Z, Qi X. Applications and developments of gene therapy drug delivery systems for genetic diseases. Asian Journal of Pharmaceutical Sciences 2021;16:687-703. [DOI: 10.1016/j.ajps.2021.05.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Hudry E, Vandenberghe LH. Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality. Neuron 2019;101:839-62. [DOI: 10.1016/j.neuron.2019.02.017] [Cited by in Crossref: 92] [Cited by in F6Publishing: 89] [Article Influence: 30.7] [Reference Citation Analysis]
47 Mittal R, Bencie N, Langlie J, Mittal J, Eshraghi AA. Exosomes as drug delivery vehicles and biomarkers for neurological and auditory systems. J Cell Physiol 2021. [PMID: 34224589 DOI: 10.1002/jcp.30484] [Reference Citation Analysis]
48 Barnes C, Scheideler O, Schaffer D. Engineering the AAV capsid to evade immune responses. Curr Opin Biotechnol 2019;60:99-103. [PMID: 30807882 DOI: 10.1016/j.copbio.2019.01.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
49 Dombrowski T, Rankovic V, Moser T. Toward the Optical Cochlear Implant. Cold Spring Harb Perspect Med 2019;9:a033225. [PMID: 30323016 DOI: 10.1101/cshperspect.a033225] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
50 Khan N, Maurya S, Bammidi S, Jayandharan GR. AAV6 Vexosomes Mediate Robust Suicide Gene Delivery in a Murine Model of Hepatocellular Carcinoma. Mol Ther Methods Clin Dev 2020;17:497-504. [PMID: 32258213 DOI: 10.1016/j.omtm.2020.03.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
51 Meliani A, Boisgerault F, Fitzpatrick Z, Marmier S, Leborgne C, Collaud F, Simon Sola M, Charles S, Ronzitti G, Vignaud A, van Wittenberghe L, Marolleau B, Jouen F, Tan S, Boyer O, Christophe O, Brisson AR, Maguire CA, Mingozzi F. Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors. Blood Adv 2017;1:2019-31. [PMID: 29296848 DOI: 10.1182/bloodadvances.2017010181] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 8.8] [Reference Citation Analysis]
52 Kim YR, Baek JI, Kim SH, Kim MA, Lee B, Ryu N, Kim KH, Choi DG, Kim HM, Murphy MP, Macpherson G, Choo YS, Bok J, Lee KY, Park JW, Kim UK. Therapeutic potential of the mitochondria-targeted antioxidant MitoQ in mitochondrial-ROS induced sensorineural hearing loss caused by Idh2 deficiency. Redox Biol 2019;20:544-55. [PMID: 30508699 DOI: 10.1016/j.redox.2018.11.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
53 Delmaghani S, El-Amraoui A. Inner Ear Gene Therapies Take Off: Current Promises and Future Challenges. J Clin Med 2020;9:E2309. [PMID: 32708116 DOI: 10.3390/jcm9072309] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
54 Sahoo S, Kariya T, Ishikawa K. Targeted delivery of therapeutic agents to the heart. Nat Rev Cardiol 2021;18:389-99. [PMID: 33500578 DOI: 10.1038/s41569-020-00499-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Schiller LT, Lemus-Diaz N, Rinaldi Ferreira R, Böker KO, Gruber J. Enhanced Production of Exosome-Associated AAV by Overexpression of the Tetraspanin CD9. Mol Ther Methods Clin Dev 2018;9:278-87. [PMID: 29707602 DOI: 10.1016/j.omtm.2018.03.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
56 Stanimirovic DB, Sandhu JK, Costain WJ. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier. BioDrugs 2018;32:547-59. [PMID: 30306341 DOI: 10.1007/s40259-018-0309-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
57 Naples JG, Miller LE, Ramsey A, Li D. Cochlear protein biomarkers as potential sites for targeted inner ear drug delivery. Drug Deliv Transl Res 2020;10:368-79. [PMID: 31741303 DOI: 10.1007/s13346-019-00692-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Peters CW, Maguire CA, Hanlon KS. Delivering AAV to the Central Nervous and Sensory Systems. Trends Pharmacol Sci 2021;42:461-74. [PMID: 33863599 DOI: 10.1016/j.tips.2021.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Duncan GA. Integrative approaches to enhance adeno-associated viral gene delivery. J Control Release 2021;341:44-50. [PMID: 34785314 DOI: 10.1016/j.jconrel.2021.11.013] [Reference Citation Analysis]
60 Orefice NS, Souchet B, Braudeau J, Alves S, Piguet F, Collaud F, Ronzitti G, Tada S, Hantraye P, Mingozzi F, Ducongé F, Cartier N. Real-Time Monitoring of Exosome Enveloped-AAV Spreading by Endomicroscopy Approach: A New Tool for Gene Delivery in the Brain. Mol Ther Methods Clin Dev 2019;14:237-51. [PMID: 31440523 DOI: 10.1016/j.omtm.2019.06.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
61 Barani B, Rajasingh S, Rajasingh J. Exosomes: Outlook for Future Cell-Free Cardiovascular Disease Therapy. Adv Exp Med Biol 2017;998:285-307. [PMID: 28936747 DOI: 10.1007/978-981-10-4397-0_19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
62 Yoshimura H, Shibata SB, Ranum PT, Moteki H, Smith RJH. Targeted Allele Suppression Prevents Progressive Hearing Loss in the Mature Murine Model of Human TMC1 Deafness. Mol Ther 2019;27:681-90. [PMID: 30686588 DOI: 10.1016/j.ymthe.2018.12.014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 10.7] [Reference Citation Analysis]
63 Breglio AM, May LA, Barzik M, Welsh NC, Francis SP, Costain TQ, Wang L, Anderson DE, Petralia RS, Wang YX, Friedman TB, Wood MJ, Cunningham LL. Exosomes mediate sensory hair cell protection in the inner ear. J Clin Invest 2020;130:2657-72. [PMID: 32027617 DOI: 10.1172/JCI128867] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 24.0] [Reference Citation Analysis]
64 Hu Z, Tao L, Deng M. Postnatal Changes of Neural Stem Cells in the Mammalian Auditory Cortex. Int J Mol Sci 2021;22:1550. [PMID: 33557044 DOI: 10.3390/ijms22041550] [Reference Citation Analysis]
65 Cring MR, Sheffield VC. Gene therapy and gene correction: targets, progress, and challenges for treating human diseases. Gene Ther 2020. [PMID: 33037407 DOI: 10.1038/s41434-020-00197-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
66 Bankoti K, Generotti C, Hwa T, Wang L, O'Malley BW Jr, Li D. Advances and challenges in adeno-associated viral inner-ear gene therapy for sensorineural hearing loss. Mol Ther Methods Clin Dev 2021;21:209-36. [PMID: 33850952 DOI: 10.1016/j.omtm.2021.03.005] [Reference Citation Analysis]
67 Balachandran B, Yuana Y, Schumacher U. Extracellular vesicles-based drug delivery system for cancer treatment. Cogent Medicine 2019;6:1635806. [DOI: 10.1080/2331205x.2019.1635806] [Cited by in Crossref: 24] [Article Influence: 8.0] [Reference Citation Analysis]
68 Ma Y, Wise AK, Shepherd RK, Richardson RT. New molecular therapies for the treatment of hearing loss. Pharmacol Ther. 2019;200:190-209. [PMID: 31075354 DOI: 10.1016/j.pharmthera.2019.05.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
69 Kim MA, Ryu N, Kim HM, Kim YR, Lee B, Kwon TJ, Bok J, Kim UK. Targeted Gene Delivery into the Mammalian Inner Ear Using Synthetic Serotypes of Adeno-Associated Virus Vectors. Mol Ther Methods Clin Dev 2019;13:197-204. [PMID: 30805407 DOI: 10.1016/j.omtm.2019.01.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
70 Rufino-ramos D, Albuquerque PR, Carmona V, Perfeito R, Nobre RJ, Pereira de Almeida L. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases. Journal of Controlled Release 2017;262:247-58. [DOI: 10.1016/j.jconrel.2017.07.001] [Cited by in Crossref: 128] [Cited by in F6Publishing: 120] [Article Influence: 25.6] [Reference Citation Analysis]
71 Saari H, Turunen T, Lõhmus A, Turunen M, Jalasvuori M, Butcher SJ, Ylä-Herttuala S, Viitala T, Cerullo V, Siljander PRM, Yliperttula M. Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery. J Extracell Vesicles 2020;9:1747206. [PMID: 32363012 DOI: 10.1080/20013078.2020.1747206] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
72 Ding N, Lee S, Lieber-Kotz M, Yang J, Gao X. Advances in genome editing for genetic hearing loss. Adv Drug Deliv Rev 2021;168:118-33. [PMID: 32387678 DOI: 10.1016/j.addr.2020.05.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
73 Gong Y, Berenson A, Laheji F, Gao G, Wang D, Ng C, Volak A, Kok R, Kreouzis V, Dijkstra IM, Kemp S, Maguire CA, Eichler F. Intrathecal Adeno-Associated Viral Vector-Mediated Gene Delivery for Adrenomyeloneuropathy. Hum Gene Ther 2019;30:544-55. [PMID: 30358470 DOI: 10.1089/hum.2018.079] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
74 Yang T, Cai C, Peng A, Liu J, Wang Q. Exosomes derived from cochlear spiral ganglion progenitor cells prevent cochlea damage from ischemia-reperfusion injury via inhibiting the inflammatory process. Cell Tissue Res 2021. [PMID: 34155579 DOI: 10.1007/s00441-021-03468-x] [Reference Citation Analysis]
75 Liu B, Li Z, Huang S, Yan B, He S, Chen F, Liang Y. AAV-Containing Exosomes as a Novel Vector for Improved Gene Delivery to Lung Cancer Cells. Front Cell Dev Biol 2021;9:707607. [PMID: 34485293 DOI: 10.3389/fcell.2021.707607] [Reference Citation Analysis]
76 Omichi R, Shibata SB, Morton CC, Smith RJH. Gene therapy for hearing loss. Hum Mol Genet 2019;28:R65-79. [PMID: 31227837 DOI: 10.1093/hmg/ddz129] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
77 Taiber S, Avraham KB. Genetic Therapies for Hearing Loss: Accomplishments and Remaining Challenges. Neurosci Lett 2019;713:134527. [PMID: 31586696 DOI: 10.1016/j.neulet.2019.134527] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
78 György B, Lööv C, Zaborowski MP, Takeda S, Kleinstiver BP, Commins C, Kastanenka K, Mu D, Volak A, Giedraitis V, Lannfelt L, Maguire CA, Joung JK, Hyman BT, Breakefield XO, Ingelsson M. CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease. Mol Ther Nucleic Acids 2018;11:429-40. [PMID: 29858078 DOI: 10.1016/j.omtn.2018.03.007] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 14.5] [Reference Citation Analysis]
79 György B, Maguire CA. Extracellular vesicles: nature's nanoparticles for improving gene transfer with adeno-associated virus vectors. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2018;10:e1488. [PMID: 28799250 DOI: 10.1002/wnan.1488] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
80 Hao J, Li SK. Inner ear drug delivery: Recent advances, challenges, and perspective. European Journal of Pharmaceutical Sciences 2019;126:82-92. [DOI: 10.1016/j.ejps.2018.05.020] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 13.0] [Reference Citation Analysis]
81 Claridge B, Lozano J, Poh QH, Greening DW. Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities. Front Cell Dev Biol 2021;9:734720. [PMID: 34616741 DOI: 10.3389/fcell.2021.734720] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
82 Ivanchenko MV, Hanlon KS, Devine MK, Tenneson K, Emond F, Lafond JF, Kenna MA, Corey DP, Maguire CA. Preclinical testing of AAV9-PHP.B for transgene expression in the non-human primate cochlea. Hear Res 2020;394:107930. [PMID: 32145977 DOI: 10.1016/j.heares.2020.107930] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
83 Ahmed H, Shubina-Oleinik O, Holt JR. Emerging Gene Therapies for Genetic Hearing Loss. J Assoc Res Otolaryngol 2017;18:649-70. [PMID: 28815315 DOI: 10.1007/s10162-017-0634-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 9.2] [Reference Citation Analysis]
84 Zhang W, Kim SM, Wang W, Cai C, Feng Y, Kong W, Lin X. Cochlear Gene Therapy for Sensorineural Hearing Loss: Current Status and Major Remaining Hurdles for Translational Success. Front Mol Neurosci 2018;11:221. [PMID: 29997477 DOI: 10.3389/fnmol.2018.00221] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
85 Tay LS, Palmer N, Panwala R, Chew WL, Mali P. Translating CRISPR-Cas Therapeutics: Approaches and Challenges. CRISPR J 2020;3:253-75. [PMID: 32833535 DOI: 10.1089/crispr.2020.0025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
86 Lee J, Nist-Lund C, Solanes P, Goldberg H, Wu J, Pan B, Schneider BL, Holt JR. Efficient viral transduction in mouse inner ear hair cells with utricle injection and AAV9-PHP.B. Hear Res 2020;394:107882. [PMID: 31980281 DOI: 10.1016/j.heares.2020.107882] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
87 Azparren-Angulo M, Royo F, Gonzalez E, Liebana M, Brotons B, Berganza J, Goñi-de-Cerio F, Manicardi N, Abad-Jordà L, Gracia-Sancho J, Falcon-Perez JM. Extracellular vesicles in hepatology: Physiological role, involvement in pathogenesis, and therapeutic opportunities. Pharmacol Ther 2021;218:107683. [PMID: 32961265 DOI: 10.1016/j.pharmthera.2020.107683] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Askew C, Chien WW. Adeno-associated virus gene replacement for recessive inner ear dysfunction: Progress and challenges. Hear Res 2020;394:107947. [PMID: 32247629 DOI: 10.1016/j.heares.2020.107947] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
89 Baumgartner JE, Baumgartner LS, Baumgartner ME, Moore EJ, Messina SA, Seidman MD, Shook DR. Progenitor cell therapy for acquired pediatric nervous system injury: Traumatic brain injury and acquired sensorineural hearing loss. Stem Cells Transl Med 2021;10:164-80. [PMID: 33034162 DOI: 10.1002/sctm.20-0026] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Zhao X, Wu D, Ma X, Wang J, Hou W, Zhang W. Exosomes as drug carriers for cancer therapy and challenges regarding exosome uptake. Biomed Pharmacother 2020;128:110237. [PMID: 32470747 DOI: 10.1016/j.biopha.2020.110237] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
91 Jiang P, Zhang S, Cheng C, Gao S, Tang M, Lu L, Yang G, Chai R. The Roles of Exosomes in Visual and Auditory Systems. Front Bioeng Biotechnol 2020;8:525. [PMID: 32582658 DOI: 10.3389/fbioe.2020.00525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
92 Hanlon KS, Kleinstiver BP, Garcia SP, Zaborowski MP, Volak A, Spirig SE, Muller A, Sousa AA, Tsai SQ, Bengtsson NE, Lööv C, Ingelsson M, Chamberlain JS, Corey DP, Aryee MJ, Joung JK, Breakefield XO, Maguire CA, György B. High levels of AAV vector integration into CRISPR-induced DNA breaks. Nat Commun 2019;10:4439. [PMID: 31570731 DOI: 10.1038/s41467-019-12449-2] [Cited by in Crossref: 92] [Cited by in F6Publishing: 82] [Article Influence: 30.7] [Reference Citation Analysis]
93 Kalinec GM, Cohn W, Whitelegge JP, Faull KF, Kalinec F. Preliminary Characterization of Extracellular Vesicles From Auditory HEI-OC1 Cells. Ann Otol Rhinol Laryngol 2019;128:52S-60S. [DOI: 10.1177/0003489419836226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
94 Zhang ZG, Buller B, Chopp M. Exosomes - beyond stem cells for restorative therapy in stroke and neurological injury. Nat Rev Neurol. 2019;15:193-203. [PMID: 30700824 DOI: 10.1038/s41582-018-0126-4] [Cited by in Crossref: 138] [Cited by in F6Publishing: 144] [Article Influence: 69.0] [Reference Citation Analysis]
95 Thakur A, Ke X, Chen YW, Motallebnejad P, Zhang K, Lian Q, Chen HJ. The mini player with diverse functions: extracellular vesicles in cell biology, disease, and therapeutics. Protein Cell 2021. [PMID: 34374936 DOI: 10.1007/s13238-021-00863-6] [Reference Citation Analysis]
96 Thorpe RK, Smith RJH. Future directions for screening and treatment in congenital hearing loss. Precis Clin Med 2020;3:175-86. [PMID: 33209510 DOI: 10.1093/pcmedi/pbaa025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
97 György B, Meijer EJ, Ivanchenko MV, Tenneson K, Emond F, Hanlon KS, Indzhykulian AA, Volak A, Karavitaki KD, Tamvakologos PI, Vezina M, Berezovskii VK, Born RT, O'Brien M, Lafond JF, Arsenijevic Y, Kenna MA, Maguire CA, Corey DP. Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human Primate. Mol Ther Methods Clin Dev 2019;13:1-13. [PMID: 30581889 DOI: 10.1016/j.omtm.2018.11.003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 14.3] [Reference Citation Analysis]
98 Fu P, Zhang J, Li H, Mak M, Xu W, Tao Z. Extracellular vesicles as delivery systems at nano-/micro-scale. Adv Drug Deliv Rev 2021;:113910. [PMID: 34358539 DOI: 10.1016/j.addr.2021.113910] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Lin X, Li G, Zhang Y, Zhao J, Lu J, Gao Y, Liu H, Li GL, Yang T, Song L, Wu H. Hearing consequences in Gjb2 knock-in mice: implications for human p.V37I mutation. Aging (Albany NY) 2019;11:7416-41. [PMID: 31562289 DOI: 10.18632/aging.102246] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
100 Casey G, Askew C, Brimble MA, Samulski RJ, Davidoff AM, Li C, Walters BJ. Self-complementarity in adeno-associated virus enhances transduction and gene expression in mouse cochlear tissues. PLoS One 2020;15:e0242599. [PMID: 33227033 DOI: 10.1371/journal.pone.0242599] [Reference Citation Analysis]
101 Gurunathan S, Kang MH, Qasim M, Khan K, Kim JH. Biogenesis, Membrane Trafficking, Functions, and Next Generation Nanotherapeutics Medicine of Extracellular Vesicles. Int J Nanomedicine 2021;16:3357-83. [PMID: 34040369 DOI: 10.2147/IJN.S310357] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
102 Soekmadji C, Li B, Huang Y, Wang H, An T, Liu C, Pan W, Chen J, Cheung L, Falcon-Perez JM, Gho YS, Holthofer HB, Le MTN, Marcilla A, O'Driscoll L, Shekari F, Shen TL, Torrecilhas AC, Yan X, Yang F, Yin H, Xiao Y, Zhao Z, Zou X, Wang Q, Zheng L. The future of Extracellular Vesicles as Theranostics - an ISEV meeting report. J Extracell Vesicles 2020;9:1809766. [PMID: 33144926 DOI: 10.1080/20013078.2020.1809766] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
103 Leake PA, Akil O, Lang H. Neurotrophin gene therapy to promote survival of spiral ganglion neurons after deafness. Hear Res 2020;394:107955. [PMID: 32331858 DOI: 10.1016/j.heares.2020.107955] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
104 Duan L, Xu L, Xu X, Qin Z, Zhou X, Xiao Y, Liang Y, Xia J. Exosome-mediated delivery of gene vectors for gene therapy. Nanoscale 2021;13:1387-97. [PMID: 33350419 DOI: 10.1039/d0nr07622h] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
105 Volak A, LeRoy SG, Natasan JS, Park DJ, Cheah PS, Maus A, Fitzpatrick Z, Hudry E, Pinkham K, Gandhi S, Hyman BT, Mu D, GuhaSarkar D, Stemmer-Rachamimov AO, Sena-Esteves M, Badr CE, Maguire CA. Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery. J Neurooncol 2018;139:293-305. [PMID: 29767307 DOI: 10.1007/s11060-018-2889-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
106 Wiklander OPB, Brennan MÁ, Lötvall J, Breakefield XO, El Andaloussi S. Advances in therapeutic applications of extracellular vesicles. Sci Transl Med 2019;11:eaav8521. [PMID: 31092696 DOI: 10.1126/scitranslmed.aav8521] [Cited by in Crossref: 216] [Cited by in F6Publishing: 218] [Article Influence: 108.0] [Reference Citation Analysis]
107 Sancho-Albero M, Rubio-Ruiz B, Pérez-López AM, Sebastián V, Martín-Duque P, Arruebo M, Santamaría J, Unciti-Broceta A. Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis. Nat Catal 2019;2:864-72. [PMID: 31620674 DOI: 10.1038/s41929-019-0333-4] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 23.7] [Reference Citation Analysis]